Alfredo Berruti

University of Brescia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Davide FARINA

Full Professor of Radiology

University of Brescia

ITALY

View details

David Penton

University of Zurich

SWITZERLAND

View details

Diego Ferone

Assistant Professor

University of Genova

ITALY

View details

Mirko D'Onofrio

Full Professor

University of Verona

ITALY

View details

Marika Vezzoli

Assistant Professor of Biostatistics (MED/01)

University of Brescia

ITALY

View details

MATTEO ROTA

Associate Professor of Medical Statistics

University of Brescia

ITALY

View details

Sandra SIGALA

Associate Professor of Pharmacology

University of Brescia

ITALY

View details

Massimo Falconi

Full Professor of Surgery

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alfredo Berruti

Research Interests

Explore related searches

Contact this professor

Articles (12)

Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric Measurements

Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group

Correction: Sigala et al. A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. Cells 2022, 11, 1439

Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status

Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study

A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis

Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes

Letter to the Editor From Cosentini et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma

Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view

Collaborators (8)

Davide FARINA

David Penton

Diego Ferone

Mirko D'Onofrio

Marika Vezzoli

MATTEO ROTA

Sandra SIGALA

Massimo Falconi

Make your next move.